ASTP Site Visit to Cancer Research Technology Friday 3 April 2009 Draft Programme
10.00
Arrival, Registration and Tea/Coffee
10.30
Overview of CRT - What’s Different? (What makes CRT unique, our history, the future.)
11.15
Commercialisation Modes (The strengths and weakness of different commercialisation modes, illustrated by CRT case studies including: Licence/ Collaboration/ Spin Out/ Collaboration SPV/ Clinical Development Partnerships.)
12.30
Lunch - with Posters and Meet the CRT Team (Buffet lunch accompanied by posters highlighting aspects of CRT, hosted by CRT staff.)
13.45
Bridging the Gap - Learnings from the Discovery Labs (The CRT Discovery Lab model and how this is producing what Pharma/Biotech wants to buy.)
14.45
Internationalisation - CRT Inc (Boston, USA) and CTx (Melbourne, Australia) (Learnings from establishing a foreign tech transfer subsidiary – what works (CRT Inc). Developing a national drug discovery resource leveraging public research – CTx, its relationship with CRT and its development.)
15.30
Tea/Coffee
15.45
Summary
16.00
Depart